Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials / Daniele, G; Arenare, L; Scambia, G; Pisano, C; Sorio, R; Breda, E; De Placido, S; Savarese, A; Ferrandina, G; Raspagliesi, F; Panici, Pb; Ferro, A; Rimanti, A; Cormio, G; Lorusso, D; Cecere, Sc; Scalone, S; Marsico, Va; Cardalesi, C; Cognetti, F; Salutari, V; Attademo, L; Guizzaro, L; Schettino, C; Piccirillo, Mc; Perrone, F; Gallo, C; Pignata, S. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - 154:1(2019), pp. 83-88. [10.1016/j.ygyno.2019.04.012]
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials
Panici PB;Cognetti F;Schettino C;
2019
Abstract
Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.File | Dimensione | Formato | |
---|---|---|---|
Daniele_Prognostic-role_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
454.51 kB
Formato
Adobe PDF
|
454.51 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.